Related Experiment Videos
[Prostatic endometrioid carcinoma: a case report]
1Department of Urology, Tokyo Metropolitan Tama Geriatric Hospital.
Hinyokika Kiyo. Acta Urologica Japonica
|December 13, 1997
Summary
Endometrioid carcinoma of the prostate, a rare cancer, can mimic benign prostatic hyperplasia. This case highlights its potential for recurrence and coexistence with adenocarcinoma, emphasizing the need for vigilant monitoring and hormonal therapy.
Area of Science:
- Oncology
- Uropathology
Background:
- Prostate cancer diagnosis typically involves evaluating prostate-specific antigen (PSA) levels and digital rectal examination findings.
- Benign prostatic hyperplasia (BPH) is a common condition in older men, often presenting with urinary retention.
Observation:
- An 89-year-old male presented with urinary retention and elevated PSA, initially suspected as BPH.
- Histopathology revealed endometrioid carcinoma with positive PSA staining, despite a benign digital rectal exam.
- Recurrence was noted after 37 months, with biopsy showing mixed endometrioid carcinoma and acinar adenocarcinoma.
Findings:
- Endometrioid carcinoma of the prostate is a rare entity that can present similarly to BPH.
- This tumor type can exhibit PSA positivity, complicating initial diagnosis.
- The disease demonstrated potential for recurrence and could coexist with conventional acinar adenocarcinoma.
Implications:
- This case underscores the importance of thorough histopathological examination for accurate prostate cancer diagnosis, especially in atypical presentations.
- Hormonal therapy, specifically estrogen administration, proved effective in managing recurrent and mixed-type prostate cancer.
- Long-term monitoring is crucial for patients diagnosed with rare prostate cancer subtypes to detect recurrence or progression early.